Potentially 61% undervalued, is this FTSE 250 stock an unmissable buy?

Spire Healthcare is a FTSE 250 stock with amazing forecast earnings growth. More and more people are paying to avoid the NHS’s huge waiting lists.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Older couple walking in park

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With NHS waiting lists at all-time highs, this FTSE 250 stock has an enviable growth path.

Spire Healthcare, a leading independent hospital group in the UK, announced robust results for the first half of 2023.

The company’s strong performance, with a 13.1% increase in revenue driven by growing demand, reflects a broader trend. More individuals are turning to private healthcare, partly due to long NHS wait times exacerbated by the pandemic.

Spire says its success is a testament to its strategic adaptability and commitment to quality care.

Not optimistic enough?

Spire has a sky-high price-to-earnings (P/E) ratio of 42.6, suggesting investors are very optimistic about the company’s potential.

At the same time, a discounted cash flow model shows the stock is undervalued by 61%.

Typically, a high P/E ratio, such as Spire’s, would be a red flag, signalling market exuberance and a possible bubble waiting to burst.

However, the substantial undervaluation suggested by the discounted cash flow analysis implies the opposite.

In this rare case, investors might actually not be optimistic enough, despite the eye-watering P/E ratio.

Indeed, analysts forecast the company can grow its earnings at a whopping 36% a year. If Spire really can live up to this expectation, its stock price should soar. That’s because right now the market is pricing in a much gloomier scenario, in defiance of analysts’ cheer.

Inelastic demand

In 2023, inflation and the cost-of-living crisis loomed large, yet Spire appeared somewhat insulated. Research suggests that their typical private patient prioritises healthcare spending, potentially safeguarding the company from the worst financial pressures faced by other sectors.

Political risks abound

Of course, Spire has its challenges. The risks of investing in the UK’s private healthcare providers are obvious. Just five years ago, the Labour Party manifesto proposed an end to private providers in the NHS. If Jeremy Corbyn had won, that would have annihilated around one-quarter of Spire Healthcare’s revenue.

Another scenario worth considering is one in which the NHS’s waiting lists are dramatically reduced due to a massive funding injection. In that case, it would no longer seem so appealing to pay thousands of pounds out of pocket to jump the queue. Spire’s biggest rival is any business’ worst nightmare: a state-backed organisation handing out the same service with a price tag of zero.

But that’s only one scenario. Personally, I am not optimistic about the NHS’s ability to cope. The ongoing pressures on the NHS, exacerbated by an ageing population, seem likely to continue diverting more individuals and employers towards private healthcare options. Spire could also benefit from the shortage of skilled labourers in certain sectors in the UK if private health insurance increasingly becomes used as a way to retain talented workers.

I plan to open a small position in Spire when I next have spare cash to invest.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Mark Tovey has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

My favourite FTSE 100 passive income stock that keeps the Christmas coffers full

The holiday season is expensive and can leave many consumers struggling to make ends meet. Here’s how I use a…

Read more »

Investing Articles

The latest growth forecasts suggest the Glencore share price will hit 555p!

Harvey Jones has been disappointed by the performance of the Glencore share price since he bought the commodity stock last…

Read more »

Dividend Shares

A closer look at the 11% dividend yield forecast for Phoenix Group shares

Phoenix Group shares have one of the highest dividend yields in the FTSE 100 index today. Could this be a…

Read more »

Investing Articles

If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for…

Read more »

Investing Articles

Up 40%, but experts forecast the easyJet share price could soon hit 664p! Time to buy?

The easyJet share price has been flying lately and stock analysts are predicting more fun to come. But there's only…

Read more »

Storytelling image of a multiethnic senior couple in love - Elderly married couple dating outdoors, love emotions and feelings
Investing Articles

Worried about tax raids? Here’s how I’m targeting a £44,526 passive income with shares

Investing in a Self-Invested Personal Pension (SIPP) or Individual Savings Account (ISA) can supercharge one's passive income, says Royston Wild.

Read more »

Young black man looking at phone while on the London Overground
Investing Articles

A FTSE 250 share I’d buy and aim to hold for 20 years!

This FTSE 250 share has soared more than 2,000% during the past decade. Our writer Royston Wild thinks it has…

Read more »

Bournemouth at night with a fireworks display from the pier
Investing Articles

3 heavily discounted UK shares to consider buying in November

These three UK shares have been dragged down and our writer believes they're trading below their true value as we…

Read more »